Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy.

ABSTRACT: Immunotherapy is among the most effective approaches for treating cancer. One of the key aspects for successful immunotherapy is to achieve a strong and stable antitumor immune response. Modern immune checkpoint therapy demonstrates that cancer can be defeated. However, it also points out the weaknesses of immunotherapy, as not all tumors respond to therapy and the co-administration of different immunomodulators may be severely limited due to their systemic toxicity. Nevertheless, there is an established way through which to increase the immunogenicity of immunotherapy-by the use of adjuvants. These enhance the immune response without inducing such severe adverse effects. One of the most well-known and studied adjuvant strategies to improve immunotherapy efficacy is the use of metal-based

SUBMITTER: Naletova I 

PROVIDER: S-EPMC10222518 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature